UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Therapeutic vaccines for cancer: an overview of clinical trials

Nature reviews. Clinical oncology, 2014-09, Vol.11 (9), p.509-524

2014

Volltextzugriff (PDF)

Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules

The Journal of immunology (1950), 2013-03, Vol.190 (5), p.2381-2390

2013

Volltextzugriff (PDF)

Tumor-released microvesicles as vehicles of immunosuppression

Cancer research (Chicago, Ill.), 2007-04, Vol.67 (7), p.2912-2915

2007

Volltextzugriff (PDF)

Interleukin-12: Biological Properties and Clinical Application

Clinical cancer research, 2007-08, Vol.13 (16), p.4677-4685

2007

Volltextzugriff (PDF)

Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients

Clinical cancer research, 2010-02, Vol.16 (3), p.800-813

2010

Volltextzugriff (PDF)

Phenotypic Characterization of Human Colorectal Cancer Stem Cells

Proceedings of the National Academy of Sciences - PNAS, 2007-06, Vol.104 (24), p.10158-10163

2007

Volltextzugriff (PDF)

Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

Journal of clinical oncology, 2007-06, Vol.25 (18), p.2546-2553

2007

Volltextzugriff (PDF)

Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial

The lancet oncology, 2012-09, Vol.13 (9), p.879-886

2012

Volltextzugriff (PDF)

Unique Human Tumor Antigens: Immunobiology and Use in Clinical Trials

Journal of Immunology, 2007-02, Vol.178 (4), p.1975-1979

2007

Volltextzugriff (PDF)

Phase III Comparison of Vitespen, an Autologous Tumor-Derived Heat Shock Protein gp96 Peptide Complex Vaccine, With Physician's Choice of Treatment for Stage IV Melanoma: The C-100-21 Study Group

Journal of clinical oncology, 2008-02, Vol.26 (6), p.955-962

2008

Volltextzugriff (PDF)

Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancer

Cancer Immunology, Immunotherapy, 2015-01, Vol.64 (1), p.99-104

2015

Volltextzugriff (PDF)

Melanoma Cancer Stem Cells: Markers and Functions

Cancers, 2016-03, Vol.8 (3), p.34

Parmiani, Giorgio

2016

Volltextzugriff (PDF)

Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients

BMC cancer, 2018-10, Vol.18 (1), p.983-983, Article 983

2018

Volltextzugriff (PDF)

Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles

The Journal of experimental medicine, 2002-05, Vol.195 (10), p.1303-1316

2002

Volltextzugriff (PDF)

TNK cells (NKG2D⁺ CD8⁺ or CD4⁺ T lymphocytes) in the control of human tumors

Cancer Immunology, Immunotherapy, 2009-05, Vol.58 (5), p.801-808

2009

Volltextzugriff (PDF)

Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients

Oncoimmunology, 2017-01, Vol.6 (7), p.e1323618-e1323618

2017

Volltextzugriff (PDF)

Vaccination with Autologous Tumor-derived Heat-Shock Protein Gp96 after Liver Resection for Metastatic Colorectal Cancer

Clinical cancer research, 2003-08, Vol.9 (9), p.3235-3245

2003

Volltextzugriff (PDF)

Immunological markers and clinical outcome of advanced melanoma patients receiving ipilimumab plus fotemustine in the NIBIT-M1 study

Oncoimmunology, 2016-02, Vol.5 (2), p.e1071007-e1071007

2016

Volltextzugriff (PDF)

Interferon Adjuvant to Radical Nephrectomy in Robson Stages II and III Renal Cell Carcinoma: A Multicentric Randomized Study

Journal of clinical oncology, 2001-01, Vol.19 (2), p.425-431

2001

Volltextzugriff (PDF)

BRAF alterations are associated with complex mutational profiles in malignant melanoma

Oncogene, 2004-08, Vol.23 (35), p.5968-5977

2004

Volltextzugriff (PDF)

Integrating Immune Checkpoint Blockade with Anti-Neo/Mutated Antigens Reactivity to Increase the Clinical Outcome of Immunotherapy

Vaccines, 2015-05, Vol.3 (2), p.420-428

2015

Volltextzugriff (PDF)

The early antitumor immune response is necessary for tumor growth: Re-visiting Prehn's hypothesis in the human melanoma system

Oncoimmunology, 2012-09, Vol.1 (6), p.930-934

2012

Volltextzugriff (PDF)

A pilot Phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanoma

Oncoimmunology, 2014-11, Vol.3 (11), p.e963406-e963406

2014

Volltextzugriff (PDF)

Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy

Immunological investigations, 2017-04, Vol.46 (3), p.221-238

2017

Volltextzugriff (PDF)

1 – 25 von 410

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(394)
Mit Volltextzugriff
(354)

Publikationsform

Artikel
(409)
Tagungsberichte
(1)

Sprache

Englisch
(410)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Therapeutic vaccines for cancer: an overview of clinical trials

Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules

Tumor-released microvesicles as vehicles of immunosuppression

Interleukin-12: Biological Properties and Clinical Application

Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients

Phenotypic Characterization of Human Colorectal Cancer Stem Cells

Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial

Unique Human Tumor Antigens: Immunobiology and Use in Clinical Trials

Phase III Comparison of Vitespen, an Autologous Tumor-Derived Heat Shock Protein gp96 Peptide Complex Vaccine, With Physician's Choice of Treatment for Stage IV Melanoma: The C-100-21 Study Group

Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancer

Melanoma Cancer Stem Cells: Markers and Functions

Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients

Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles

TNK cells (NKG2D⁺ CD8⁺ or CD4⁺ T lymphocytes) in the control of human tumors

Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients

Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

Vaccination with Autologous Tumor-derived Heat-Shock Protein Gp96 after Liver Resection for Metastatic Colorectal Cancer

Immunological markers and clinical outcome of advanced melanoma patients receiving ipilimumab plus fotemustine in the NIBIT-M1 study

Interferon Adjuvant to Radical Nephrectomy in Robson Stages II and III Renal Cell Carcinoma: A Multicentric Randomized Study

BRAF alterations are associated with complex mutational profiles in malignant melanoma

Integrating Immune Checkpoint Blockade with Anti-Neo/Mutated Antigens Reactivity to Increase the Clinical Outcome of Immunotherapy

The early antitumor immune response is necessary for tumor growth: Re-visiting Prehn's hypothesis in the human melanoma system

A pilot Phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanoma

Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy

Suchergebnisse filtern